Literature DB >> 6774339

Evolution of a new enzymatic function by recombination within a gene.

B G Hall, T Zuzel.   

Abstract

Mutations that alter the ebgA gene so that the evolved beta-galactosidase (ebg) enzyme of Escherichia coli can hydrolyze lactose fall into two classes: class I mutants use only lactose, whereas class II mutants use lactulose as well as lactose. Neither class uses galactosylarabinose effectively. In this paper we show that when both a class I and a class II mutation are present in the same ebgA gene, ebg enzyme acquires a specificity for galactosylarabinose. Although galactosylarbinose utilization can evolve as the consequence of sequential spontaneous mutations, it can also evolve via intragenic recombination in crosses between class I and class II ebgA+ mutant strains. We show that the sites for class I and class II mutations lie about 1 kilobase, or about a third of the gene, apart in ebgA. Implications of these findings with respect to the evolution of new metabolic functions discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6774339      PMCID: PMC349650          DOI: 10.1073/pnas.77.6.3529

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  Regulation of newly evolved enzymes. II. The ebg repressor.

Authors:  B G Gall; D L Hartl
Journal:  Genetics       Date:  1975-11       Impact factor: 4.562

Review 2.  Recalibrated linkage map of Escherichia coli K-12.

Authors:  B J Bachmann; K B Low; A L Taylor
Journal:  Bacteriol Rev       Date:  1976-03

3.  Number of mutations required to evolve a new lactase function in Escherichia coli.

Authors:  B G Hall
Journal:  J Bacteriol       Date:  1977-01       Impact factor: 3.490

4.  Regulation of newly evolved enzymes. III Evolution of the ebg repressor during selection for enhanced lactase activity.

Authors:  B G Hall; N D Clarke
Journal:  Genetics       Date:  1977-02       Impact factor: 4.562

5.  Second naturally occurring beta-galactosidase in E. coli.

Authors:  D L Hartl; B G Hall
Journal:  Nature       Date:  1974-03-08       Impact factor: 49.962

6.  Experimental evolution of a new enzymatic function. Kinetic analysis of the ancestral (ebg) and evolved (ebg) enzymes.

Authors:  B G Hall
Journal:  J Mol Biol       Date:  1976-10-15       Impact factor: 5.469

7.  Experimental evolution of a new enzymatic function. II. Evolution of multiple functions for ebg enzyme in E. coli.

Authors:  B G Hall
Journal:  Genetics       Date:  1978-07       Impact factor: 4.562

8.  Regulation of newly evolved enzymes. I. Selection of a novel lactase regulated by lactose in Escherichia coli.

Authors:  B G Hall; D L Hartl
Journal:  Genetics       Date:  1974-03       Impact factor: 4.562

  8 in total
  7 in total

1.  How long did it take for life to begin and evolve to cyanobacteria?

Authors:  A Lazcano; S L Miller
Journal:  J Mol Evol       Date:  1994-12       Impact factor: 2.395

2.  The ebg operon consists of at least two genes.

Authors:  B G Hall; T Zuzel
Journal:  J Bacteriol       Date:  1980-12       Impact factor: 3.490

3.  A neutral theory of biogenesis.

Authors:  A Ferracin
Journal:  Orig Life       Date:  1981-12

4.  DNA sequence analysis of artificially evolved ebg enzyme and ebg repressor genes.

Authors:  B G Hall; P W Betts; J C Wootton
Journal:  Genetics       Date:  1989-12       Impact factor: 4.562

5.  Transgalactosylation activity of ebg beta-galactosidase synthesizes allolactose from lactose.

Authors:  B G Hall
Journal:  J Bacteriol       Date:  1982-04       Impact factor: 3.490

6.  An automated flow for directed evolution based on detection of promiscuous scaffolds using spatial and electrostatic properties of catalytic residues.

Authors:  Sandeep Chakraborty
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

7.  Comparative Genomic Analysis of Escherichia coli O157:H7 Isolated from Super-Shedder and Low-Shedder Cattle.

Authors:  Krysty D Munns; Rahat Zaheer; Yong Xu; Kim Stanford; Chad R Laing; Victor P J Gannon; L Brent Selinger; Tim A McAllister
Journal:  PLoS One       Date:  2016-03-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.